Technology

Aethlon Medical

$2.72
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.12 (+4.71%) Today
+$0.05 (+1.87%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell AEMD and other stocks, options, and ETFs commission-free!

About AEMD

Aethlon Medical, Inc. Common Stock, also called Aethlon Medical, is a therapeutic technology company, which focuses on addressing global health and biodefense needs. It develops Aethlon Hemopurifier, a medical device that targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The firm operates through two segments: Aethlon and ESI. The Aethlon segment involves in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in May 1998 and is headquartered in San Diego, CA. The listed name for AEMD is Aethlon Medical, Inc. Common Stock.

CEO
Charles J. Fisher
Employees
8
Headquarters
San Diego, California
Founded
1998
Market Cap
32.28M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
614.21K
High Today
$2.77
Low Today
$2.57
Open Price
$2.60
Volume
567.43K
52 Week High
$4.34
52 Week Low
$1.18

Collections

AEMD Earnings

-$1.29
-$0.86
-$0.43
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Feb 10, After Hours

You May Also Like

PHI
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure